Lennham Pharmaceuticals
About:
Lennham Pharmaceuticals helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry.
Website: https://www.lennham.com/
Description:
Lennham Pharmaceuticals is a pharmaceutical company that helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry. It focuses on the application of deuterium chemistry to well-characterized compounds that have enabled it to develop a pipeline of products such as deuterium-enriched forms of psilocybin, and caffeine.
Total Funding Amount:
$3.53M
Headquarters Location:
Concord, Massachusetts, United States
Founded Date:
2019-01-01
Contact Email:
info(AT)lennham.com
Founders:
BRADFORD SIPPY
Number of Employees:
101-250
Last Funding Date:
2023-04-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai